pPPC011
(Plasmid
#171143)
-
PurposeExpression of Sp.pCas9-dCas9 and BBa_J23107-MCP-SoxS(R93A/S101A) on pRK2-KmR plasmid
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 171143 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRK2-KmR
-
Backbone manufacturerJesse Zalatan
- Backbone size w/o insert (bp) 4577
- Total vector size (bp) 10215
-
Vector typeBacterial Expression, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsMedium Copy in P. putida
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameSp.pCas9-dCas9_BBa_J23107-MCP-SoxS(R93A, S101A)
-
SpeciesS. pyogenes (dCas9), MS2 (MCP), E. coli (SoxS)
-
Insert Size (bp)5642
-
MutationSoxS has R93A and S101A mutations
- Promoter Sp.pCas9, BBa_J23107
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer ggggagaggcggtttgcgta
- 3′ sequencing primer cgtttgtgatggcttccatg (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Alternative names: pCK145, pRK2-KmR_Sp.pCas9-dCas9_BBa_J23107-MCP-SoxS(R93A/S101A)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pPPC011 was a gift from Jesse Zalatan (Addgene plasmid # 171143 ; http://n2t.net/addgene:171143 ; RRID:Addgene_171143) -
For your References section:
Portable bacterial CRISPR transcriptional activation enables metabolic engineering in Pseudomonas putida. Kiattisewee C, Dong C, Fontana J, Sugianto W, Peralta-Yahya P, Carothers JM, Zalatan JG. Metab Eng. 2021 Apr 27. pii: S1096-7176(21)00063-X. doi: 10.1016/j.ymben.2021.04.002. 10.1016/j.ymben.2021.04.002 PubMed 33930546